Characterization of a Prospective Cohort of Women With PCOS
Metabolic and Endocrinological Characterization of a Prospective Cohort of Women With PCOS
2 other identifiers
observational
500
1 country
1
Brief Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT. As part of the project, a Biobank with fasting blood samples from participants is established.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 21, 2013
CompletedFirst Posted
Study publicly available on registry
December 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
April 25, 2023
April 1, 2023
15 years
November 21, 2013
April 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bone mass density (BMD)
BMD measured by DXA scans and ExtremeCT scans.
baseline
Secondary Outcomes (1)
Stress hormones
Baseline
Study Arms (1)
PCOS
Women fulfilling at least two of the three Rotterdam criteria for PCOS, including * Irregular menstrual cycle * Clinical/biochemical hyperandrogenemia * Polycystic ovaries
Eligibility Criteria
Women with PCOS, diagnosed by the Rotterdam criteria which include at least two of the following: * irregular mestrual cycle * polycystic ovaries * biochemical/clinical hyperandrogenemia
You may qualify if:
- PCOS
You may not qualify if:
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Endocrinology, Odense University Hospital
Odense, 5000, Denmark
Biospecimen
Blood and urine samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorte Glintborg, MD PhD
Department of Endocrinology, Odense University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DMSci
Study Record Dates
First Submitted
November 21, 2013
First Posted
December 13, 2013
Study Start
January 1, 2012
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
April 25, 2023
Record last verified: 2023-04